Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 1, 1987
The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography
N L Foster, A F VanDerSpek, M S Aldrich, et al.
Annals of Neurology
|
September 1, 1996
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
D E Kuhl, S Minoshima, J A Fessler, et al.
Neurology
|
March 17, 1999
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease
D E Kuhl, R A Koeppe, S Minoshima, et al.
Neurology
|
September 1, 1996
Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation
E J Cochran, D A Bennett, L Cervenáková, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
June 1, 1992
Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism
M J Boivin, B Giordani, S Berent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1997
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity
T Vander Borght, S Minoshima, B Giordani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1990
Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT
J M Mountz, J G Modell, N L Foster, et al.
Neurology
|
October 1, 1994
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
T Lynch, M Sano, K S Marder, et al.
Neurology
|
May 26, 2004
Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis
P Moretti, A P Lieberman, E A Wilde, et al.
British Journal of Clinical Pharmacology
|
October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease
R J Fontana, T M deVries, T F Woolf, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 1, 1987
The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography
N L Foster, A F VanDerSpek, M S Aldrich, et al.
Annals of Neurology
|
September 1, 1996
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
D E Kuhl, S Minoshima, J A Fessler, et al.
Neurology
|
March 17, 1999
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease
D E Kuhl, R A Koeppe, S Minoshima, et al.
Neurology
|
September 1, 1996
Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation
E J Cochran, D A Bennett, L Cervenáková, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
June 1, 1992
Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism
M J Boivin, B Giordani, S Berent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1997
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity
T Vander Borght, S Minoshima, B Giordani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1990
Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT
J M Mountz, J G Modell, N L Foster, et al.
Neurology
|
October 1, 1994
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
T Lynch, M Sano, K S Marder, et al.
Neurology
|
May 26, 2004
Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis
P Moretti, A P Lieberman, E A Wilde, et al.
British Journal of Clinical Pharmacology
|
October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease
R J Fontana, T M deVries, T F Woolf, et al.
Page
of 9